![](/img/cover-not-exists.png)
H05Phase 1/2 study of nivolumab with or without ipilimumab for treatment of recurrent small cell lung cancer (SCLC): CA209-032
Antonia, S.J., Bendell, J., Taylor, M., Calvo, E., Jäger, D., de Braud, F., Ott, P.A., Pietanza, M.C., Horn, L., Le, D.T., Morse, M.A., López-Martin, J.A., Ascierto, P.A., Christensen, O., Grosso, J.FVolume:
26
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv343.05
Date:
October, 2015
File:
PDF, 36 KB
english, 2015